FZMD - Fuse Medical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.4500
0.0000 (0.00%)
At close: 10:21AM EST
Stock chart is not supported by your current browser
Previous Close0.4500
Open0.0000
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.4500 - 0.4500
52 Week Range0.4000 - 2.0000
Volume1
Avg. Volume642
Market Cap31.6M
Beta (3Y Monthly)1.24
PE Ratio (TTM)N/A
EPS (TTM)-0.04
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire19 days ago

    Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM

    Fuse Medical, Inc., , , a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM , an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.

  • Business Wire26 days ago

    Fuse Medical, Inc. Files Quarterly Report on Form 10-Q

    Fuse Medical, Inc., , , announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2018 of the Fiscal Year 2018 with the United States Securities and Exchange Commission, on Tuesday November 13, 2018.

  • Business Wire4 months ago

    Fuse Medical, Inc. Completes Acquisition of Maxim Surgical

    Fuse Medical, Inc. , announced the completion of the acquisition of Palm Springs Partners, LLC d/b/a Maxim Surgical , a manufacturing company in the spinal fusion device market and full-service medical device and distribution company .

  • Business Wire7 months ago

    Fuse Medical, Inc. Files Quarterly Report on Form 10-Q

    Fuse Medical, Inc., (FZMD), (“Fuse” or the “Company”), announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2018, with the United States Securities and Exchange Commission, (the “SEC”) on Tuesday, May 15, 2018. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to report our first quarter of 2018 results with increases of approximately 7% and 14%, for net revenue and gross profit, respectively, compared to the same period one year ago. With the successful completion of our acquisition of CPM Medical Consultants, LLC, reflected positively in our 2017 Annual Report on Form 10-K filing, all of us at Fuse are very excited about what this partnership will mean for our next phase of growth, as well as the benefits it offers our customers.

  • Business Wire11 months ago

    Fuse Medical, Inc. Announces Engagement of Montgomery, Coscia, Greilich, LLP

    Fuse Medical, Inc., , , announced the appointment of Montgomery, Coscia, Greilich, LLP, , headquarter in Plano, Texas, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017.

  • Business Wire11 months ago

    Fuse Medical, Inc. Completes Acquisition of CPM Medical Consultants, LLC

    Fuse Medical, Inc., , , announced the completion of the acquisition of CPM Medical Consultants, LLC , a privately-owned nationwide distributor of medical device implants and biologics, .

  • Business Wire11 months ago

    FUSE MEDICAL (FZMD) SHAREHOLDER ALERT – Andrews & Springer LLC is Investigating Fuse Medical, Inc. for Potential Breaches of Fiduciary Duty

    Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Fuse Medical, Inc.

  • Business Wirelast year

    Fuse Medical, Inc. Signs Definitive Purchase Agreement to Acquire CPM Medical Consultants, LLC

    Fuse Medical, Inc., , , announced today that it signed a definitive purchase agreement to acquire CPM Medical Consultants, LLC , a privately-owned nationwide distributor of medical device implants and biologics.